Taken together, uPA and uPAR are physiological targets of TTP in various cancer types, and the concept of TTP-mediated downregulation of uPA and uPAR seems to be promising to attenuate the malignancy of tumors [75]. This evidence concerns the gene PLAUR and cancer.